| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2005 | EP1244641B1 Thiazolyl amide derivatives |
| 04/13/2005 | EP1242416B1 Substituted isoxazolines and their use as antibacterial agents |
| 04/13/2005 | EP1212060B1 Use of nicotine or derivatives thereof and l-dopa in a medicine for treating neurological diseases, in particular parkinson disease |
| 04/13/2005 | EP1212052B1 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 04/13/2005 | EP1134222B1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 04/13/2005 | EP1115409A4 Composition for extending post meal satiety |
| 04/13/2005 | EP1113785B1 Clear aqueous solutions of bile acids |
| 04/13/2005 | EP1105728B1 Modulating multiple lineage kinase proteins |
| 04/13/2005 | EP1077709B1 Arsenic sulfide compounds free of arsenic oxide for the treatment of hematological cancers |
| 04/13/2005 | EP1059917B1 Pharmaceutical preparation for use in anti-asthma therapy |
| 04/13/2005 | EP1033982B1 Agents for combating neospora spec |
| 04/13/2005 | EP1017408B1 Use of tethrahydrolipstatin in the treatment of diabetes type ii |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | EP0975349B1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 04/13/2005 | EP0966486B1 Method for producing regular porous cellulose pearls |
| 04/13/2005 | EP0966257B1 Barrier to plaque formation |
| 04/13/2005 | EP0930893B1 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/13/2005 | EP0871488B1 Production of analgesic synergy by co-administration of sub-analgesic doses of a mu opioid agonist and a kappa-2 opioid agonist |
| 04/13/2005 | CN1606694A Methods for monitoring and treating amyotrophic lateral sclerosis |
| 04/13/2005 | CN1606623A Production of stilbenes in transgenic plants and the method of producing thereof |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606559A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606558A Novel cephalosporin compounds and process for preparing the same |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606553A Oxytocin agonistenoxytocin agonisten |
| 04/13/2005 | CN1606552A Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 04/13/2005 | CN1606550A Benzothia(dia)zine derivatives and their use as AMPA modulators |
| 04/13/2005 | CN1606548A Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1606472A Adsorbent for phosphoric acid |
| 04/13/2005 | CN1606463A Methods of treating bacterial infections in dogs and cats |
| 04/13/2005 | CN1606462A Composition based on etyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne |
| 04/13/2005 | CN1606450A Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 04/13/2005 | CN1606449A Improved use of antitumoral compound in cancer therapy |
| 04/13/2005 | CN1606448A Composition for the treatment of lupus |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1606445A Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1606442A Treatments for restless legs syndrome |
| 04/13/2005 | CN1606441A Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606439A Cis-imidazolines |
| 04/13/2005 | CN1606438A 5HT4 partial agonist pharmaceutical compositions |
| 04/13/2005 | CN1606437A Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1606435A Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 04/13/2005 | CN1606433A Methods for wet granulating azithromycin |
| 04/13/2005 | CN1606432A Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/13/2005 | CN1606430A Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 04/13/2005 | CN1606427A Stable surfactant compositions for suspending components |
| 04/13/2005 | CN1606406A Mitocidal compositions and methods |
| 04/13/2005 | CN1605586A Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives |
| 04/13/2005 | CN1605344A Traceless stock solution(prescription) |
| 04/13/2005 | CN1605343A Application of skimming in the preparing process of medicine for preparing and treating kidney function failure |
| 04/13/2005 | CN1605342A Breviscapine injection for perfusion and its preparing process |
| 04/13/2005 | CN1605341A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605340A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605339A Usage of 1H-indole-2, 3-diketone and its derivant in the process for preparing anemia treating medicine and medicine for treating anemia |
| 04/13/2005 | CN1605338A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605337A Application of cnidium fruit element in the preparing process of medicine for preventing and treating Sexual dysfunction |
| 04/13/2005 | CN1605335A Antivirus dihydromyricetin and myricetin containing pharmaceutical composition |
| 04/13/2005 | CN1605334A Usage of composition in preparing medicine for tumorous disease treatment |
| 04/13/2005 | CN1605333A Application of BAPTA derivative in the preparing process of clinical medicine |
| 04/13/2005 | CN1605332A Fibrauretine injection for perfusion and its preparing process |
| 04/13/2005 | CN1196797C Diagnostics and therapeutics for glaucoma |
| 04/13/2005 | CN1196795C Novel method for preparing synthesis intermediates |
| 04/13/2005 | CN1196709C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 04/13/2005 | CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols |
| 04/13/2005 | CN1196704C Process for preparing inhibitors of nucleoside metabolism |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 04/13/2005 | CN1196698C Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents |
| 04/13/2005 | CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV |
| 04/13/2005 | CN1196696C New thiochromane derivatives and use as thrombin inhibitors |
| 04/13/2005 | CN1196693C Neutralizing agent for toxin of microorganism belonging to genus clostridium |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196683C Amino-compound |
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196680C Modulators of dopamine neurotransmission |
| 04/13/2005 | CN1196678C Prostaglandin E1 derivatives |
| 04/13/2005 | CN1196673C (-)-Verbenzone derivs. |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/13/2005 | CN1196496C Dry acid-chitosan complexes |
| 04/13/2005 | CN1196494C Medicine powder for aphtha of external use |
| 04/13/2005 | CN1196491C Ointment for healing trauumatic injury |
| 04/13/2005 | CN1196489C Perfusion liquid preparations for ophthalmic operations |
| 04/13/2005 | CN1196488C Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 04/13/2005 | CN1196487C 单位剂量形式 The unit dosage form |
| 04/13/2005 | CN1196486C Ziprasidone suspension liquid |
| 04/13/2005 | CN1196485C Compositions for use against parasitic protozoa |
| 04/13/2005 | CN1196483C Compositions for improivng fertility |